HealthAugust 12, 2026
ziftomenib
zif-TOM-uh-nib
Definition
A targeted oncology drug used as a menin inhibitor for treating certain types of acute myeloid leukemia (AML).
Etymology
As a pharmaceutical name, ziftomenib is a constructed drug name derived from the suffix '-menib,' which denotes a category of kinase or related enzyme inhibitors, combined with a unique prefix selected for the specific molecule.
In the news
In this article, ziftomenib is identified as the active ingredient in Kura Oncology's lead drug, KOMZIFTI, which the company is advancing as a foundational therapy for AML patients.
Earnings call transcript: Kura Oncology tops Q2 2026 estimates as launch gains
Read the full article ↗Investing.com